...
机译:巨细胞动脉炎和高山动脉炎的生物治疗
Dijon Univ Hosp Francois Mitterrand Hosp Dept Internal Med &
Clin Immunol Dijon France;
Univ Barcelona Inst Invest Biomed August Pi &
Sunyer IDIBAPS Hosp Clin Vasc Res Unit Dept;
Univ Barcelona Inst Invest Biomed August Pi &
Sunyer IDIBAPS Hosp Clin Vasc Res Unit Dept;
Univ Barcelona Inst Invest Biomed August Pi &
Sunyer IDIBAPS Hosp Clin Vasc Res Unit Dept;
Univ Barcelona Inst Invest Biomed August Pi &
Sunyer IDIBAPS Hosp Clin Vasc Res Unit Dept;
Univ Barcelona Inst Invest Biomed August Pi &
Sunyer IDIBAPS Hosp Clin Vasc Res Unit Dept;
Univ Barcelona Inst Invest Biomed August Pi &
Sunyer IDIBAPS Hosp Clin Vasc Res Unit Dept;
Dijon Univ Hosp Francois Mitterrand Hosp Dept Internal Med &
Clin Immunol Dijon France;
Dijon Univ Hosp Francois Mitterrand Hosp Dept Internal Med &
Clin Immunol Dijon France;
Univ Barcelona Inst Invest Biomed August Pi &
Sunyer IDIBAPS Hosp Clin Vasc Res Unit Dept;
Giant cell arteritis; Takayasu arteritis; Anti-TNF-alpha agents; Tocilizumab; Ustekinumab; Rituximab; Abatacept;
机译:巨细胞动脉炎和高山动脉炎的生物治疗
机译:托珠单抗用于治疗大血管血管炎(巨细胞动脉炎,Takayasu动脉炎)和风湿性多肌痛
机译:大细胞性动脉炎和高津动脉炎:EpidemioSogicai,诊断和治疗方面
机译:炎症血管综合征,巨型细胞和高山动脉炎肌瘤病毒治疗分析
机译:培养的马单核吞噬细胞和肺动脉内皮细胞的马病毒性动脉炎病毒的发病机理的表征。
机译:成功的抗病毒治疗巨细胞动脉炎和高津动脉炎
机译:成功的抗病毒治疗巨型细胞动脉炎和高山动脉炎